Obesity, smoking and gender type as cardiovascular risk factors among COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007
Underweight – a risk factor for COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 366s Year: 2006
Body composition by bioelectrical impedance predicts mortality in COPD patients Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005
The impact of comorbidities related to BMI in COPD patients Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Body mass index (BMI) is an independent risk factor for exacerbation in patients with COPD Source: Annual Congress 2008 - COPD and comorbidities Year: 2008
BMI is reduced in COPD. Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020
Obesity and risk of subsequent hospitalisation with pneumonia Source: Eur Respir J 2010; 36: 1330-1336 Year: 2010
OSA and cardiovascular risk in women Source: 5th Sleep and Breathing Conference Year: 2019
Comparison of BMI and central obesity between asthma and COPD patients Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008
The prevalence and risk factors of COPD in women Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008
Associations of genetic risk and smoking with incident COPD Source: Eur Respir J, 59 (2) 2101320; 10.1183/13993003.01320-2021 Year: 2022
Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021
Risk factors of death in patients with COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study Source: ERJ Open Res, 8 (1) 00628-2021; 10.1183/23120541.00628-2021 Year: 2022
Smoking and BMI in COPD and non-COPD patients Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals Year: 2021
Prevalence of comorbidity in patients with COPD and its effect on mortality Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003
COVID-19 prevalence, risk factors and outcomes in COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011
Identifying risk groups for any cause hospitalizations in COPD patients Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017
Age cohort mortality differences for respiratory and cardiovascular causes of death Source: Eur Respir J 2001; 18: Suppl. 33, 151s Year: 2001